Leonid Dubrovsky
0000-0003-2799-4765
Publication & Citation Trends
Publications
0 total
Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma
Cited by 2
Semantic Scholar
Prevalence of medical conditions or comorbidities influencing first-line therapy in unresectable hepatocellular carcinoma in the United States OA
Cited by 1
Semantic Scholar
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Cited by 130
Semantic Scholar
Real-world treatment patterns among U.S. adults with unresectable hepatocellular carcinoma (uHCC) eligible for locoregional therapy (LRT).
Cited by 0
Semantic Scholar
LEAP-002 long-term follow-up: Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma.
Cited by 4
Semantic Scholar
Lenvatinib plus pembrolizumab versus lenvatinib alone as first-line therapy for advanced hepatocellular carcinoma: Longer-term efficacy and safety results from the phase 3 LEAP-002 study.
Cited by 9
Semantic Scholar
LBA3 Transarterial chemoembolization (TACE) with or without lenvatinib (len) + pembrolizumab (pembro) for intermediate-stage hepatocellular carcinoma (HCC): Phase III LEAP-012 study
Cited by 31
Semantic Scholar
Health-related quality of life (HRQoL) impact of lenvatinib (len) plus pembrolizumab (pembro) versus len plus placebo (pbo) as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC): Phase 3 LEAP-002 study.
Cited by 2
Semantic Scholar
Research Topics
Hepatocellular Carcinoma Treatment and Prognosis
(21)
CAR-T cell therapy research
(17)
Monoclonal and Polyclonal Antibodies Research
(14)
Renal and related cancers
(14)
Cancer Immunotherapy and Biomarkers
(9)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
Memorial Sloan Kettering Cancer Center
Children's National
Johns Hopkins University
Kettering University